Physician profile
Nirav Shah
NPI 1710277918
$355.94
in general payments reported to CMS, 2019-2025
8 companies · $60.92 in 2025
The $60.92 reported for 2025 was less than what a typical Vascular Neurology provider received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $129 · 2022: $71.25 · 2023: $44.11 · 2024: $50.25 · 2025: $60.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $155.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $125.06 | 2021-2023 | Reyvow, Emgality |
| Emd Serono, INC. | $77.64 | 2022-2025 | |
| Biogen, INC. | $56.11 | 2021-2024 | Skyclarys |
| Sunovion Pharmaceuticals INC. | $32.08 | 2021 | |
| Medline Industries LP | $29.26 | 2024 | |
| Ucb, INC. | $22.40 | 2022 | |
| Sumitomo Pharma America, INC. | $13.39 | 2023 | Aptiom |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nirav Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.